Clinical Data ASCO 2026: Kelonia presents positive in vivo CAR-T data in multiple myeloma pharminent June 2, 2026
Clinical Data ASCO: Pfizer scores in lung, colorectal and prostate cancer but key readouts still to come pharminent June 2, 2026
Clinical Data AbiVax falls as safety worries cloud ‘landmark’ immune drug results pharminent June 2, 2026
Clinical Data ASCO: Summit reached with China lung data but new climb begins to prove global benefit pharminent June 1, 2026
Clinical Data Summit’s PD-1/VEGF to take center stage at ASCO, with wide impact for peers pharminent May 29, 2026
Clinical Data GSK, Ionis unveil data for hepatitis B drug touted as ‘functional cure’ pharminent May 28, 2026
Clinical Data Kailera’s three-pronged obesity shot shows promise in early trial pharminent May 27, 2026
Clinical Data Early data for heart drug affirm Lilly’s billion-dollar bet on Verve pharminent May 26, 2026
Clinical Data Lilly’s Verve gambit pays off as base editor cuts cholesterol in early study pharminent May 26, 2026
Clinical Data Kelun-Merck validate TROP2-Keytruda pairing in lung cancer with improved survival pharminent May 22, 2026
Clinical Data Lilly’s triple agonist shows bariatric surgery-like weight loss results pharminent May 21, 2026
Clinical Data BioMarin bounces back as Voxzogo performs ‘bigger than expected’ in new indication pharminent May 21, 2026
Clinical Data ATS 2026: PABPC4 gene identified as a key driver of emphysema in COPD pharminent May 21, 2026
Clinical Data ATS 2026: Long-term data show durable benefit of Trikafta for cystic fibrosis pharminent May 21, 2026
Clinical Data Beam one-ups Wave as both show promise of genetic editing for AATD pharminent May 20, 2026
Clinical Data AbbVie’s new immunology standard-bearer Skyrizi kneels to UCB’s Bimzelx in psoriatic arthritis pharminent May 20, 2026
Clinical Data Relay doubles the bar, outpacing Novartis with a 60% response in rare disease pharminent May 19, 2026
Clinical Data Relay drug shows early promise against rare blood vessel diseases pharminent May 19, 2026
Clinical Data BioMarin suffers another blow to rare disease portfolio in Phase 3 flop pharminent May 19, 2026
Clinical Data UCB reports positive outcomes for bimekizumab in psoriatic arthritis pharminent May 19, 2026
Clinical Data Merck ADC, licensed from China, hits mark in first big global trial pharminent May 18, 2026
Clinical Data Biogen’s Alzheimer’s results bolster tau theory–and Denali’s next gen candidate pharminent May 15, 2026
Clinical Data ECO 2026: SURMOUNT-MAINTAIN proves tirzepatide sustains weight loss long term pharminent May 15, 2026
Clinical Data REGENXBIO slumps after serious side effects mar Duchenne gene therapy results pharminent May 14, 2026
Clinical Data ECO 2026: REDEFINE-1 demonstrates CagriSema’s improvement in body composition pharminent May 13, 2026
